Altan M, Tu J, Milton DR, Yilmaz B, et al. Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer. Cancer 2023 May 2. doi: 10.1002/cncr.34820.
PMID: 37129197